—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock（AMRX）— 同类公司组

数据截至2026-10-07 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

Amneal Pharmaceuticals, Inc. Class A Common Stock的Closelook综合评分为55/100，在同类公司组内排名第6位（共11家）——组内评分最高的是DexCom Inc（66/100）。

名称综合动量质量估值信号距52周高点
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock55895843ok7.2%
ROVI.MC Laboratorios Farmaceuticos ROVI62277853info30.8%
ALM.MC Almirall S.A.53224669warn25.6%
FAGR.BR Fagron NV53485760info9.7%
APTX.TO Apotex Health Corp47355951——
RDY Dr. Reddy’s Laboratories Ltd ADR46294463info20.9%
SFZN.SW Siegfried Holding Ltd42284555info31.8%
DXCM DexCom Inc66838138bear9.9%
ONC BeiGene, Ltd.64816532ok5.5%
MEDP Medpace Holdings Inc63817530ok10.9%
PTGX Protagonist Therapeutics Inc60776212info12.4%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-07

Quick answers

Amneal Pharmaceuticals, Inc. Class A Common Stock在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：Laboratorios Farmaceuticos ROVI (ROVI.MC)、Almirall S.A. (ALM.MC)、Fagron NV (FAGR.BR)、Apotex Health Corp (APTX.TO)、Dr. Reddy’s Laboratories Ltd ADR (RDY)、Siegfried Holding Ltd (SFZN.SW)、DexCom Inc (DXCM)、BeiGene, Ltd. (ONC)等。

AMRX相对同类公司的评分如何？

Amneal Pharmaceuticals, Inc. Class A Common Stock的综合评分为55/100，组内排名第6位（共11家），截至2026-10-07；组内最高综合评分为DexCom Inc（66/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.